Literature DB >> 15920498

Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression.

Beata Karolewicz1, Craig A Stockmeier, Gregory A Ordway.   

Abstract

Low levels of the intracellular mediator of glutamate receptor activation, neuronal nitric oxide synthase (nNOS) were previously observed in locus coeruleus (LC) from subjects diagnosed with major depression. This finding implicates abnormalities in glutamate signaling in depression. Receptors responding to glutamate in the LC include ionotropic N-methyl-D-aspartate receptors (NMDARs). The functional NMDAR is a hetero-oligomeric structure composed of NR1 and NR2 (A-D) subunits. Tissue containing the LC and a nonlimbic LC projection area (cerebellum) was obtained from 13 and 9 matched pairs, respectively, of depressed subjects and control subjects lacking major psychiatric diagnoses. NMDAR subunit composition in the LC was evaluated in a psychiatrically normal subject. NR1 and NR2C subunit immunoreactivities in LC homogenates showed prominent bands at 120 and 135 kDa, respectively. In contrast to NRI and NR2C, very weak immunoreactivity of NR2A and NR2B subunits was observed in the LC. Possible changes in concentrations of NR1 and NR2C that might occur in depression were assessed in the LC and cerebellum. The overall amount of NR1 immunoreactivity was normal in the LC and cerebellum in depressed subjects. Amounts of NR2C protein were significantly higher (+ 61%, p = 0.003) in the LC and modestly, but not significantly, elevated in the cerebellum (+ 35%) of depressives as compared to matched controls. Higher levels of NR2C subunit implicate altered glutamatergic input to the LC in depressive disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920498      PMCID: PMC2921564          DOI: 10.1038/sj.npp.1300781

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  66 in total

Review 1.  Antidepressants for the new millennium.

Authors:  P Skolnick
Journal:  Eur J Pharmacol       Date:  1999-06-30       Impact factor: 4.432

2.  Effects of handling on extracellular levels of glutamate and other amino acids in various areas of the brain measured by microdialysis.

Authors:  W Timmerman; G Cisci; A Nap; J B de Vries; B H Westerink
Journal:  Brain Res       Date:  1999-07-03       Impact factor: 3.252

3.  The nitric oxide-cGMP system of the locus coeruleus and the hypnotic action of alpha-2 adrenergic agonists.

Authors:  Y Vulliemoz; R A Whittington; L Virag
Journal:  Brain Res       Date:  1999-12-04       Impact factor: 3.252

4.  Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.

Authors:  D P Auer; B Pütz; E Kraft; B Lipinski; J Schill; F Holsboer
Journal:  Biol Psychiatry       Date:  2000-02-15       Impact factor: 13.382

5.  Antidepressant effects of ketamine in depressed patients.

Authors:  R M Berman; A Cappiello; A Anand; D A Oren; G R Heninger; D S Charney; J H Krystal
Journal:  Biol Psychiatry       Date:  2000-02-15       Impact factor: 13.382

6.  Increased cerebrospinal fluid glutamine levels in depressed patients.

Authors:  J Levine; K Panchalingam; A Rapoport; S Gershon; R J McClure; J W Pettegrew
Journal:  Biol Psychiatry       Date:  2000-04-01       Impact factor: 13.382

7.  Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal.

Authors:  B Cuéllar; A P Fernández; I Lizasoain; M A Moro; P Lorenzo; M L Bentura; J Rodrigo; J C Leza
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

8.  Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression.

Authors:  M Y Zhu; V Klimek; G E Dilley; J W Haycock; C Stockmeier; J C Overholser; H Y Meltzer; G A Ordway
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

9.  Low nNOS protein in the locus coeruleus in major depression.

Authors:  B Karolewicz; K Szebeni; C A Stockmeier; L Konick; J C Overholser; G Jurjus; B L Roth; G A Ordway
Journal:  J Neurochem       Date:  2004-12       Impact factor: 5.372

10.  The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders.

Authors:  Sutisa Nudmamud-Thanoi; Gavin P Reynolds
Journal:  Neurosci Lett       Date:  2004-11-30       Impact factor: 3.046

View more
  22 in total

Review 1.  Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.

Authors:  Cagri Yüksel; Dost Öngür
Journal:  Biol Psychiatry       Date:  2010-08-21       Impact factor: 13.382

2.  Normal [3H]flunitrazepam binding to GABAA receptors in the locus coeruleus in major depression and suicide.

Authors:  He Zhu; Beata Karolewicz; Emily Nail; Craig A Stockmeier; Katalin Szebeni; Gregory A Ordway
Journal:  Brain Res       Date:  2006-11-21       Impact factor: 3.252

3.  Glia mechanisms in mood regulation: a novel model of mood disorders.

Authors:  Younglim Lee; Denise Gaskins; Amit Anand; Anantha Shekhar
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

4.  Effects of venlafaxine and escitalopram treatments on NMDA receptors in the rat depression model.

Authors:  Nigar Yilmaz; Arif Demirdas; Mustafa Yilmaz; Recep Sutcu; Aynur Kirbas; Medine Cumhur Cure; Ibrahim Eren
Journal:  J Membr Biol       Date:  2011-07-14       Impact factor: 1.843

Review 5.  A brief history of the development of antidepressant drugs: from monoamines to glutamate.

Authors:  Todd M Hillhouse; Joseph H Porter
Journal:  Exp Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.157

Review 6.  The role of the central noradrenergic system in behavioral inhibition.

Authors:  Eric A Stone; Yan Lin; Yasmeen Sarfraz; David Quartermain
Journal:  Brain Res Rev       Date:  2011-03-05

7.  Glutamate receptor subunit expression in the rhesus macaque locus coeruleus.

Authors:  Nigel C Noriega; Vasilios T Garyfallou; Steven G Kohama; Henryk F Urbanski
Journal:  Brain Res       Date:  2007-08-09       Impact factor: 3.252

8.  Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression.

Authors:  Anteneh M Feyissa; Agata Chandran; Craig A Stockmeier; Beata Karolewicz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-10-25       Impact factor: 5.067

9.  Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression.

Authors:  Anteneh M Feyissa; William L Woolverton; Jose J Miguel-Hidalgo; Zhixia Wang; Patrick B Kyle; Gregor Hasler; Craig A Stockmeier; Abiye H Iyo; Beata Karolewicz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-11-26       Impact factor: 5.067

10.  Glutamate signaling proteins and tyrosine hydroxylase in the locus coeruleus of alcoholics.

Authors:  Beata Karolewicz; Laurel Johnson; Katalin Szebeni; Craig A Stockmeier; Gregory A Ordway
Journal:  J Psychiatr Res       Date:  2007-05-03       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.